MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-19-2025
OpGen Long Term Debt Current 2011-2026 | OPGN
Annual Long Term Debt Current OpGen
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 174 K | 148 K | 378 K | 460 K | 964 K | 1.02 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.02 M | 148 K | 523 K |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
662 K | $ 1.65 | - | $ 2.19 M |  USA |
 |
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | USA |
 |
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | USA |
 |
Illumina
ILMN
|
79 M | $ 128.52 | - | $ 20.4 B | USA |
 |
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | USA |
 |
Lantheus Holdings
LNTH
|
3.8 M | $ 84.11 | - | $ 5.68 B | USA |
 |
Castle Biosciences
CSTL
|
1.66 M | $ 24.98 | - | $ 694 M | USA |
 |
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M |  Israel |
 |
National Research Corporation
NRC
|
451 K | $ 17.11 | - | $ 383 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
241 M | $ 27.54 | 0.02 % | $ 20 B |  Niderland |
 |
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | USA |
 |
Precipio
PRPO
|
410 K | $ 30.7 | - | $ 49.3 M | USA |
 |
Personalis
PSNL
|
7.7 M | $ 5.96 | - | $ 353 M | USA |
 |
CareDx, Inc
CDNA
|
6.52 M | $ 21.85 | - | $ 1.16 B | USA |
 |
Senseonics Holdings
SENS
|
496 K | $ 7.27 | - | $ 303 M | USA |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
 |
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
1.44 M | $ 15.6 | - | $ 472 M | USA |
 |
Thermo Fisher Scientific
TMO
|
275 M | $ 468.04 | -0.03 % | $ 176 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Twist Bioscience Corporation
TWST
|
13.8 M | $ 61.0 | - | $ 3.65 B | USA |
 |
Charles River Laboratories International
CRL
|
57.7 M | $ 171.23 | - | $ 8.49 B | USA |
 |
Guardant Health
GH
|
27.7 M | $ 88.5 | - | $ 11.1 B | USA |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
431 K | $ 1.93 | -2.08 % | $ 8.54 M | USA |
 |
Exagen
XGN
|
1.23 M | $ 2.74 | - | $ 59.1 M | USA |
 |
Medpace Holdings
MEDP
|
23.2 M | $ 421.37 | - | $ 12.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | Niderland |
 |
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | Israel |
 |
Biomerica
BMRA
|
358 K | $ 2.18 | - | $ 5.01 M | USA |
 |
ICON Public Limited Company
ICLR
|
24.3 M | $ 103.21 | - | $ 8.51 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
191 M | $ 263.43 | - | $ 21.9 B | USA |
 |
Neogen Corporation
NEOG
|
5.64 M | $ 9.45 | - | $ 2.05 B | USA |
 |
Celcuity
CELC
|
54 K | $ 125.68 | - | $ 5.88 B | USA |
 |
NeoGenomics
NEO
|
4.78 M | $ 8.61 | - | $ 1.1 B | USA |
 |
Myriad Genetics
MYGN
|
6.9 M | $ 4.83 | - | $ 447 M | USA |
 |
Natera
NTRA
|
7.64 M | $ 204.39 | - | $ 20.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
174 M | $ 196.63 | - | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M | USA |